The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: A registry of the International Global Germ Cell Tumor Collaborative Group (G3)

MLA

Olof Ståhl, et al. The Prognostic Impact of Different Tumor Marker Levels in Nonseminomatous Germ Cell Tumor Patients with Intermediate Prognosis: A Registry of the International Global Germ Cell Tumor Collaborative Group (G3). Jan. 2019. EBSCOhost, https://doi.org/10.1016/j.urolonc.2019.07.020.

APA

Olof Ståhl, Marcus Hentrich, Fadi Taza, Gabriella Cohn-Cedermark, Christoph Oing, Karin Oechsle, Arthur Gerl, Christoph Seidel, Margarida Brito, Gedske Daugaard, Alexey Tryakin, Costantine Albany, Carsten Bokemeyer, & Andrea Necchi. (2019). The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: A registry of the International Global Germ Cell Tumor Collaborative Group (G3). https://doi.org/10.1016/j.urolonc.2019.07.020

Chicago

Olof Ståhl, Marcus Hentrich, Fadi Taza, Gabriella Cohn-Cedermark, Christoph Oing, Karin Oechsle, Arthur Gerl, et al. 2019. “The Prognostic Impact of Different Tumor Marker Levels in Nonseminomatous Germ Cell Tumor Patients with Intermediate Prognosis: A Registry of the International Global Germ Cell Tumor Collaborative Group (G3),” January. doi:10.1016/j.urolonc.2019.07.020.